Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer

Citation for published version: Mathers, JC, Movahedi, M, Macrae, F, Mecklin, J-P, Moeslein, G, Olschwang, S, Eccles, D, Evans, G, Maher, ER, Bertario, L, Bisgaard, M-L, Dunlop, M, Ho, JWC, Hodgson, S, Lindblom, A, Lubinski, J, Morrison, PJ, Murday, V, Ramesar, R, Side, L, Scott, RJ, Thomas, HJW, Vasen, H, Gerdes, A-M, Barker, G, Crawford, G, Elliott, F, Pylvanainen, K, Wijnen, J, Fodde, R, Lynch, H, Bishop, DT, Burn, J & CAPP 2 Investigators 2012, 'Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial' The Lancet Oncology, vol 13, no. 12, pp. 1242-1249., 10.1016/S1470-2045(12)70475-8

[1]  D. Bishop,et al.  A Randomized Placebo-Controlled Prevention Trial of Aspirin and/or Resistant Starch in Young People with Familial Adenomatous Polyposis , 2011, Cancer Prevention Research.

[2]  J. Mathers,et al.  Cell kinetics and gene expression changes in colorectal cancer patients given resistant starch: a randomised controlled trial , 2008, Gut.

[3]  P. Møller,et al.  Guidelines for the clinical management of Lynch syndrome (hereditary non-polyposis cancer) , 2007, Journal of Medical Genetics.

[4]  E. Riboli,et al.  The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .

[5]  A. Watson.  An overview of apoptosis and the prevention of colorectal cancer. , 2006, Critical reviews in oncology/hematology.

[6]  C. Lao,et al.  Strategies for prevention of colorectal cancer: Pharmaceutical and nutritional interventions , 2004, Current treatment options in oncology.

[7]  P. Clifton,et al.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. , 2001, Physiological reviews.

[8]  T. Byers.  Diet, colorectal adenomas, and colorectal cancer. , 2000, The New England journal of medicine.

[9]  J. Mathers,et al.  Intestinal tumorigenesis in the Apc1638N mouse treated with aspirin and resistant starch for up to 5 months. , 1999, Carcinogenesis.

[10]  J. Hautvast,et al.  Nutritional Implications Of Resistant Starch , 1996, Nutrition Research Reviews.

[11]  S. Bingham,et al.  Starch intake and colorectal cancer risk: an international comparison. , 1994, British Journal of Cancer.